title: The Brain-Specific Neural Zinc Finger Transcription Factor 2b (NZF-2b/7ZFMyt1) Suppresses Cocaine Self-Administration in Rats.
abstract: Brain-specific neural-zinc-finger transcription factor-2b (NZF2b/7ZFMyt1) is induced in the mesolimbic dopaminergic region after chronic cocaine exposure and lentiviral-mediated expression of NZF2b/7ZFMyt1 in the nucleus accumbens results in decreased locomotor activity (Chandrasekar and Dreyer, 2010). In this study the role of NZF2b/7ZFMyt1 in active cocaine seeking and of its interaction with histone deacetylase on the altered behavior has been observed. Localized expression of NZF2b/7ZFMyt1 in the nucleus accumbens resulted in attenuated cocaine self-administration, whereas silencing this transcription factor with lentiviruses expressing siRNAs increased the animal's motivation to self-infuse cocaine. Low doses of sodium butyrate, a potent inhibitor of histone deacetylase, were sufficient to reverse the NZF2b/7ZFMyt1-mediated decrease in cocaine self-administration. NZF2b/7ZFMyt1 expression resulted in strong induction of transcription factors REST1 and NAC1 and of the dopamine D2 receptor, with concomitant inhibition of BDNF and its receptor TrkB. We show that NZF2b/7ZFMyt1 colocalizes with histone deacetylase-2 (HDAC2), probably overcoming the suppression of transcriptional activity caused by Lingo1. These findings show that molecular adaptations mediated by NZF2b/7ZFMyt1 expression possibly lead to decreased responsiveness to the reinforcing properties of cocaine and play a prominent role in affecting the behavioral changes induced by the drug.
authors.affiliation: Division of Biochemistry, Department of Medicine, University of Fribourg Fribourg, Switzerland.
authors.forename: Vijay
authors.initials: V
authors.lastname: Chandrasekar
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Dreyer
references.citation: J Neurosci Res. 1997 Oct 15;50(2):272-90
references.pmid: 9373037
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G1000-8
references.pmid: 14726307
references.citation: Br J Pharmacol. 2008 May;154(2):327-42
references.pmid: 18345022
references.citation: J Neurosci. 2002 Apr 1;22(7):2977-88
references.pmid: 11923462
references.citation: Mol Cell Neurosci. 2004 Jan;25(1):111-23
references.pmid: 14962745
references.citation: Brain Res. 2006 Feb 3;1071(1):218-25
references.pmid: 16423334
references.citation: J Psychopharmacol. 1998;12(1):54-67
references.pmid: 9584969
references.citation: Neuron. 2000 Mar;25(3):515-32
references.pmid: 10774721
references.citation: Neuroscience. 2002;110(3):421-9
references.pmid: 11906783
references.citation: Biochem Biophys Res Commun. 2009 Jul 10;384(4):506-11
references.pmid: 19426709
references.citation: J Neurosci. 2002 Oct 1;22(19):8347-51
references.pmid: 12351707
references.citation: J Biol Chem. 2004 Jan 2;279(1):556-61
references.pmid: 14561745
references.citation: Curr Opin Pharmacol. 2009 Feb;9(1):53-8
references.pmid: 19138563
references.citation: Neuron. 2004 Jun 24;42(6):947-59
references.pmid: 15207239
references.citation: J Neurochem. 2005 Mar;92(5):1243-55
references.pmid: 15715673
references.citation: Neurosci Lett. 2008 Aug 15;441(1):72-6
references.pmid: 18599214
references.citation: Eur J Neurosci. 2007 Nov;26(10):2764-76
references.pmid: 18001274
references.citation: Mol Cell Biol. 1992 Dec;12(12):5632-9
references.pmid: 1280325
references.citation: J Neurosci. 1997 Nov 1;17(21):8147-55
references.pmid: 9334390
references.citation: Cereb Cortex. 2000 Mar;10(3):318-25
references.pmid: 10731226
references.citation: Nat Genet. 2000 Nov;26(3):277-81
references.pmid: 11062465
references.citation: J Neurochem. 2005 Jun;93(6):1444-53
references.pmid: 15935060
references.citation: Neurochem Int. 2009 Mar-Apr;54(3-4):245-52
references.pmid: 19121354
references.citation: Nat Neurosci. 2007 Aug;10(8):1029-37
references.pmid: 17618281
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):815-9
references.pmid: 12740128
references.citation: Science. 2008 Sep 19;321(5896):1690-2
references.pmid: 18802002
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19186-91
references.pmid: 16380431
references.citation: J Neurochem. 2004 Sep;90(5):1117-31
references.pmid: 15312167
references.citation: Pharmacol Biochem Behav. 2003 Apr;75(1):49-54
references.pmid: 12759112
references.citation: Glia. 1995 Aug;14(4):303-21
references.pmid: 8530187
references.citation: Neuron. 2004 Jun 24;42(6):961-72
references.pmid: 15207240
references.citation: Neuron. 2005 Oct 20;48(2):303-14
references.pmid: 16242410
references.citation: J Neurosci. 1997 Apr 1;17(7):2295-313
references.pmid: 9065491
references.citation: Nat Neurosci. 2008 Jul;11(7):737-8
references.pmid: 18575469
references.citation: Eur J Neurosci. 2005 Jul;22(2):397-403
references.pmid: 16045493
references.citation: Am J Addict. 2001 Summer;10(3):201-17
references.pmid: 11579619
references.citation: Neuroreport. 2004 Oct 25;15(15):2397-400
references.pmid: 15640763
references.citation: Eur J Neurosci. 2004 Mar;19(6):1621-33
references.pmid: 15066158
references.citation: J Neurosci. 2000 Aug 15;20(16):6210-7
references.pmid: 10934270
references.citation: Epigenetics. 2007 Oct-Dec;2(4):214-22
references.pmid: 18075316
references.citation: Cell. 2002 Nov 15;111(4):483-93
references.pmid: 12437922
references.citation: Stem Cells. 2007 Feb;25(2):354-63
references.pmid: 17082226
references.citation: Dev Neurobiol. 2008 Mar;68(4):521-41
references.pmid: 18186492
references.citation: Nat Rev Neurosci. 2007 May;8(5):355-67
references.pmid: 17453016
references.citation: EMBO J. 1990 Aug;9(8):2459-64
references.pmid: 2369898
references.citation: Psychopharmacology (Berl). 2008 Aug;199(2):169-82
references.pmid: 18551281
references.citation: J Biol Chem. 2004 Sep 24;279(39):40545-59
references.pmid: 15273246
references.citation: Behav Brain Res. 2007 Jul 19;181(1):76-84
references.pmid: 17477979
references.citation: J Neurosci. 2007 Jul 4;27(27):7117-24
references.pmid: 17611264
references.citation: J Neurochem. 2007 May;101(3):611-8
references.pmid: 17254023
references.citation: Mol Cell Neurosci. 2005 Feb;28(2):275-91
references.pmid: 15691709
references.citation: J Neurochem. 2005 Aug;94(3):786-93
references.pmid: 16033423
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: Brain Res. 2006 Jan 5;1067(1):1-12
references.pmid: 16376315
references.citation: Cell. 1996 Dec 27;87(7):1191-202
references.pmid: 8980226
references.citation: Neuroscience. 1995 Jan;64(1):71-80
references.pmid: 7708216
references.citation: Neuron. 2007 Nov 8;56(3):517-29
references.pmid: 17988634
references.citation: Mech Dev. 2002 Oct;118(1-2):209-13
references.pmid: 12351189
references.citation: Nature. 2008 Jul 3;454(7200):118-21
references.pmid: 18500330
references.citation: Nature. 1997 Oct 23;389(6653):856-60
references.pmid: 9349818
references.citation: J Neurosci. 2002 May 1;22(9):3312-20
references.pmid: 11978805
references.citation: J Neurosci. 2003 Oct 15;23(28):9418-27
references.pmid: 14561870
references.citation: J Neurosci. 2005 Dec 7;25(49):11444-54
references.pmid: 16339038
references.citation: Nat Neurosci. 2007 Aug;10(8):935-6
references.pmid: 17657232
references.citation: J Neurosci. 2004 Jun 16;24(24):5603-10
references.pmid: 15201333
references.citation: J Neurosci. 2003 Feb 1;23(3):742-7
references.pmid: 12574402
references.citation: Neurobiol Dis. 2010 Jan;37(1):86-98
references.pmid: 19786102